In the future, a multidimensional line of evidence is needed to clarify the source of GLP-1RA effects in IBD, including in vitro experiments to confirm direct actions, animal models designed to exclude metabolic interference, and clinical data adjusted for metabolic confounders
-SMA and type I collagen mRNA, which are cell activation markers, were also not increased by liraglutide (Figure 7a)
In this context, certain formulations have been developed to align with these biological mechanisms particularly those centered around Akkermansia muciniphila , butyrate-producing bacteria, and microbiome-supportive compounds
If youre hoping to avoid injections while using GLP-1 medications, understanding whats actually available versus whats in development helps set realistic expectations
L-carnitine L-tartrate 55%, bulking agent (polydextrose), flavourings, instant black tea (Camellia sinensis) leaf extract 4%, acetyl-L-carnitine 4%, sweetener (sucralose), zinc oxide, chromium (III) chloride
